HIMA (Health Industry Manufacturers Association) gets new technology evaluation contract:
This article was originally published in Clinica
Executive Summary
The US Health Industry Manufacturers Association (HIMA) has been awarded a contract to study how to introduce emerging medical technologies in a managed-care environment. The contract for the 12-month survey was awarded by the California Goldstrike Program, a network of regional technology alliances within California that works closely with the California Office of Strategic Technology. HIMA's Ted Mannen said managed care organisations would gain a better appreciation for the device innovation process and HIMA would gain new knowledge on device evaluation methods. California, he added, is home to more HIMA members than any other state.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.